Literature DB >> 32502657

Criteria for success after surgery for cervical radiculopathy-estimates for a substantial amount of improvement in core outcome measures.

Christer Mjåset1, John-Anker Zwart2, Caroline M W Goedmakers3, Timothy R Smith4, Tore K Solberg5, Margreth Grotle6.   

Abstract

BACKGROUND CONTEXT: Defining clinically meaningful success criteria from patient-reported outcome measures (PROMs) is crucial for clinical audits, research and decision-making.
PURPOSE: We aimed to define criteria for a successful outcome 3 and 12 months after surgery for cervical degenerative radiculopathy on recommended PROMs. STUDY
DESIGN: Prospective cohort study with 12 months follow-up. PATIENT SAMPLE: Patients operated at one or two levels for cervical radiculopathy included in the Norwegian Registry for Spine Surgery (NORspine) from 2011 to 2016. OUTCOME MEASURES: Neck disability index (NDI), Numeric Rating Scale for neck pain (NRS-NP) and arm pain (NRS-AP), health-related quality-of-life EuroQol 3L (EQ-5D), general health status (EQ-VAS).
METHODS: We included 2,868 consecutive cervical degenerative radiculopathy patients operated for cervical radiculopathy in one or two levels and included in the Norwegian Registry for Spine Surgery (NORspine). External criterion to determine accuracy and optimal cut-off values for success in the PROMs was the global perceived effect scale. Success was defined as "much better" or "completely recovered." Cut-off values were assessed by analyzing the area under the receiver operating curves for follow-up scores, mean change scores, and percentage change scores.
RESULTS: All PROMs showed high accuracy in defining success and nonsuccess and only minor differences were found between 3- and 12-month scores. At 12 months, the area under the receiver operating curves for follow-up scores were 0.86 to 0.91, change scores were 0.74 to 0.87, and percentage change scores were 0.74 to 0.91. Percentage scores of NDI and NRS-AP showed the best accuracy. The optimal cut-off values for each PROM showed considerable overlap across those operated due to disc herniation and spondylotic foraminal stenosis.
CONCLUSIONS: All PROMs, especially NDI and NRS-AP, showed good to excellent discriminative ability in distinguishing between a successful and nonsuccessful outcome after surgery due to cervical radiculopathy. Percentage change scores are recommended for use in research and clinical practice.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical degenerative radiculopathy; Cervical disc herniation; Cohort study; EuroQol; NECK Disability Index; Numerical rating scale; Patient-reported outcome measures; Spondylotic foraminal stenosis; Success criteria

Mesh:

Year:  2020        PMID: 32502657     DOI: 10.1016/j.spinee.2020.05.549

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  4 in total

1.  Nonoperative management of degenerative cervical radiculopathy: protocol of a systematic review.

Authors:  Joshua Plener; Carlo Ammendolia; Sheilah Hogg-Johnson
Journal:  J Can Chiropr Assoc       Date:  2022-04

2.  What is success of treatment? Expected outcome scores in cervical radiculopathy patients were much higher than the previously reported cut-off values for success.

Authors:  Mirad Taso; Jon Håvard Sommernes; Siri Bjorland; John Anker Zwart; Kaia Beck Engebretsen; Jarle Sundseth; Are Hugo Pripp; Frode Kolstad; Jens Ivar Brox
Journal:  Eur Spine J       Date:  2022-05-13       Impact factor: 2.721

3.  Clinical improvement after surgery for degenerative cervical myelopathy; A comparison of Patient-Reported Outcome Measures during 12-month follow-up.

Authors:  Christer Mjåset; John-Anker Zwart; Frode Kolstad; Tore Solberg; Margreth Grotle
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

4.  Changes in muscle ultrasound for the diagnosis of intensive care unit acquired weakness in critically ill patients.

Authors:  Weiqing Zhang; Jun Wu; Qiuying Gu; Yanting Gu; Yujin Zhao; Xiaoying Ge; Xiaojing Sun; Jun Lian; Qian Zeng
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.